Lili Zhao, Ph.D.
Affiliations: | 2006 | University of Iowa, Iowa City, IA |
Area:
StatisticsGoogle:
"Lili Zhao"Parents
Sign in to add mentor| George G. Woodworth | grad student | 2006 | University of Iowa | |
| (Bayesian decision-theoretic group sequential analysis with survival endpoints in phase II clinical trials.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Panarelli NC, Hammer STG, Lin J, et al. (2020) Reproducibility of AJCC Criteria for Classifying Deeply Invasive Colon Cancers Is Suboptimal for Consistent Cancer Staging. The American Journal of Surgical Pathology. 44: 1381-1388 |
| Li J, Wang W, Zhang Y, et al. (2020) Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. The Journal of Clinical Investigation |
| Qin A, Rengan R, Lee S, et al. (2019) A Pilot Study of Atezolizumab plus Hypofractionated Image-guided Radiotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics |
| Zhao L, Koschmann C. (2019) Integrating subgroups with mixed-type endpoints in early phase oncology trials. Statistical Methods in Medical Research. 962280219840050 |
| Kim HS, Lu S, Cao Y, et al. (2019) Abstract C28: KMT2D mediates TGF-β-induced epithelial-to-mesenchymal transition to promote more aggressive pancreatic cancer Cancer Research. 79 |
| Li W, Tanikawa T, Kryczek I, et al. (2018) Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism |
| Zeinali M, Murlidhar V, Fouladdel S, et al. (2018) Abstract 5579: Increased number of EMT-like CTCs relative to epithelial CTCs reveals signatures of poor outcomes in pancreatic cancer Cancer Research. 78: 5579-5579 |
| Harms KL, Chubb H, Zhao L, et al. (2017) Increased Expression of EZH2 in Merkel Cell Carcinoma Is Associated with Disease Progression and Poorer Prognosis. Human Pathology |
| Li H, Zhou W, Li L, et al. (2017) Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine. Neoplasia (New York, N.Y.). 19: 509-518 |
| Qin A, Street L, Cease K, et al. (2017) Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer |